TRAW
Traws Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.49
−8.50%Margins
Gross margin
100.0%
EBITDA margin
-638.5%
EBIT margin
-640.7%
Net margin
328.7%
FCF margin
-744.4%
-172.7%
Return on equity
112.4%
Return on assets
336.6%
Return on invested capital
0.30x
Asset turnover
-$18.2M
Cash from operations
$0.20
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026